Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   

Ontology Browser

Term:
EC 2.7.11.31 \{[hydroxymethylglutaryl-CoA reductase (NADPH)] kinase\} inhibitor (CHEBI:78622)
Annotations: Rat: (5644) Mouse: (5703) Human: (6087) Chinchilla: (0) Bonobo: (0) Dog: (0) Squirrel: (0) Pig: (0)
Parent Terms Term With Siblings Child Terms
EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor +   
EC 2.7.11.10 (IkappaB kinase) inhibitor +   
EC 2.7.11.11 (cAMP-dependent protein kinase) inhibitor +   
EC 2.7.11.12 (cGMP-dependent protein kinase) inhibitor +   
EC 2.7.11.13 (protein kinase C) inhibitor +   
EC 2.7.11.17 (Ca(2+)/calmodulin-dependent protein kinase) inhibitor +   
EC 2.7.11.18 (myosin-light-chain kinase) inhibitor +   
EC 2.7.11.20 (elongation factor 2 kinase) inhibitor +  
EC 2.7.11.21 (polo kinase) inhibitor +  
EC 2.7.11.22 (cyclin-dependent kinase) inhibitor +   
EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor +   
EC 2.7.11.26 (tau-protein kinase) inhibitor +   
EC 2.7.11.30 (receptor protein serine/threonine kinase) inhibitor +   
EC 2.7.11.31 \{[hydroxymethylglutaryl-CoA reductase (NADPH)] kinase\} inhibitor +   
An EC 2.7.11.* (protein-serine/threonine kinase) inhibitor that interferes with the action of any [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase (EC 2.7.11.31).

Synonyms
Related Synonyms: 3-hydroxy-3-methylglutaryl coenzyme A reductase kinase inhibitor ;   3-hydroxy-3-methylglutaryl coenzyme A reductase kinase inhibitors ;   3-hydroxy-3-methylglutaryl-CoA reductase kinase inhibitor ;   3-hydroxy-3-methylglutaryl-CoA reductase kinase inhibitors ;   AMP-activated protein kinase inhibitor ;   AMP-activated protein kinase inhibitors ;   AMPK inhibitor ;   AMPK inhibitors ;   ATP:[hydroxymethylglutaryl-CoA reductase (NADPH)] phosphotransferase inhibitor ;   ATP:[hydroxymethylglutaryl-CoA reductase (NADPH)] phosphotransferase inhibitors ;   EC 2.7.11.31 inhibitor ;   EC 2.7.11.31 inhibitors ;   EC 2.7.11.31 {[hydroxymethylglutaryl-CoA reductase (NADPH)] kinase} inhibitors ;   HMG-CoA reductase kinase inhibitor ;   HMG-CoA reductase kinase inhibitors ;   STK29 inhibitor ;   STK29 inhibitors ;   [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase inhibitor ;   [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase inhibitors ;   [hydroxymethylglutaryl-CoA reductase (NADPH2)] kinase inhibitor ;   [hydroxymethylglutaryl-CoA reductase (NADPH2)] kinase inhibitors ;   beta-hydroxy-beta-methylglutaryl-CoA reductase kinase inhibitor ;   beta-hydroxy-beta-methylglutaryl-CoA reductase kinase inhibitors ;   hydroxymethylglutaryl coenzyme A reductase kinase (phosphorylating) inhibitor ;   hydroxymethylglutaryl coenzyme A reductase kinase (phosphorylating) inhibitors ;   hydroxymethylglutaryl coenzyme A reductase kinase inhibitor ;   hydroxymethylglutaryl coenzyme A reductase kinase inhibitors ;   hydroxymethylglutaryl-CoA reductase kinase inhibitor ;   hydroxymethylglutaryl-CoA reductase kinase inhibitors ;   reductase kinase inhibitor ;   reductase kinase inhibitors
Xrefs: Wikipedia:AMP-activated_protein_kinase

paths to the root

NHLBI Logo

RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.